Evaluating the Automated Accellix® Platform against Conventional Flow Cytometry for Cell Therapy Samples

This poster evaluates the automated Accellix platform against conventional flow cytometry for cell therapy samples. Using microfluidic cartridge assays and an auto-gating algorithm, the platform delivers results in about 30 minutes with minimal analyst hands on time. The Accellix platform showed strong agreement with conventional flow cytometry for key leukocyte subsets with low variability across cryopreserved and activation-reagent treated PBMCs, CD19 CAR T drug product, and Streck CD Chex controls. These findings support the Accellix platform as a GMP friendly option for in process phenotyping and quality control of cell therapy products.